The Latest Breaking News from Medtronic

A whale with a lot of money to spend has taken a noticeably bullish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 10 strange trades.

The U.S. Food and Drug Administration has issued a Class I recall, the agency's most serious category, for certain tracheal tubes made by Medtronic.

A whale with a lot of money to spend has taken a noticeably bearish stance on Medtronic. Looking at options history for Medtronic (NYSE:MDT) we detected 17 strange trades.

 

Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. Medtronic is the world's largest medical device maker with a portfolio of glucose monitors, stents, insulin pumps, pacemakers, and catheters. It serves patients in over 150 countries.

Dasha Makarenko urgently needed treatment after she fled Ukraine with her family following the Russian invasion.

Saudi Arabia and the United States signed 18 partnership agreements in fields including energy, communications, space and healthcare during a visit by US President Joe Biden. The agreements include deals with US aerospace and defense firms Boeing and Raytheon, as well as healthcare companies Medtronic, Digital Diagnostics, and IQVIA, according…

Medtronic on Tuesday announced a new partnership with CathWorks, establishing the framework for a $585 million acquisition of the digital health company.

Federal regulators this week upgraded the recall of Medtronic's HeartWare Ventricular Assist Device to a Class 1 recall, its most serious classification.

Within the last quarter, Medtronic (NYSE:MDT) has observed the following analyst ratings:

Someone with a lot of money to spend has taken a bullish stance on Medtronic (NYSE:MDT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.